Free Trial

Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership

Arcutis Biotherapeutics logo
$14.62 -0.19 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$14.86 +0.25 (+1.68%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7,771.23
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$2.21 M
Get ARQT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARQT Insider Buying and Selling by Quarter

Remove Ads

Arcutis Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2025Howard G WelgusDirectorSell10,000$13.00$130,000.00  
3/3/2025Patrick BurnettInsiderSell2,819$13.03$36,731.57  
2/3/2025Howard G WelgusDirectorSell10,000$12.71$127,100.00  
2/3/2025Masaru MatsudaInsiderSell8,338$12.70$105,892.60  
1/2/2025Howard G WelgusDirectorSell10,000$14.67$146,700.00  
12/31/2024Patrick BurnettInsiderSell1,691$14.00$23,674.00  
12/20/2024Todd Franklin WatanabeInsiderSell15,000$15.17$227,550.00  
12/2/2024Howard G WelgusDirectorSell10,000$12.51$125,100.00  
11/30/2024Larry Todd EdwardsInsiderBuy1,093$7.11$7,771.23  
11/22/2024Patrick BurnettInsiderSell16,023$10.14$162,473.22  
11/19/2024Masaru MatsudaInsiderSell1,775$9.68$17,182.00  
11/15/2024Patrick BurnettInsiderSell100$10.03$1,003.00  
11/11/2024Terrie CurranDirectorSell8,687$10.85$94,253.95  
11/4/2024Masaru MatsudaInsiderSell5,015$8.68$43,530.20  
11/1/2024Howard G WelgusDirectorSell10,000$8.65$86,500.00  
10/2/2024Larry Todd EdwardsSVPSell3,725$10.01$37,287.25  
10/1/2024Howard G WelgusDirectorSell10,000$9.26$92,600.00  
9/24/2024David Joseph TopperCFOSell11,626$9.48$110,214.48  
9/3/2024Howard G WelgusDirectorSell10,000$10.77$107,700.00  
8/19/2024Patrick BurnettInsiderSell1,728$8.29$14,325.12  
8/2/2024Masaru MatsudaInsiderSell5,220$9.02$47,084.40  
8/1/2024Howard G WelgusDirectorSell10,000$9.87$98,700.00  
7/1/2024Howard G WelgusDirectorSell10,000$9.31$93,100.00  
5/30/2024Patrick BurnettInsiderSell23,000$8.75$201,250.00  
5/28/2024Masaru MatsudaInsiderSell1,775$9.01$15,992.75  
5/17/2024Larry Todd EdwardsSVPSell7,640$8.98$68,607.20  
(Data available from 1/1/2013 forward)

ARQT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Arcutis Biotherapeutics includes David Joseph Topper, David W Osborne, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Orbimed Advisors Llc, Patricia A Turney, Patrick Burnett, Scott L Burrows, Terrie Curran, and Todd Franklin Watanabe. Learn more on insiders at ARQT.

9.50% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings.

The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), and Life Sciences Viii L Frazier ($200,000.00).

Insiders have purchased a total of 81,093 ARQT shares in the last 24 months for a total of $207,771.23 bought.

The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Howard G Welgus ($1,228,330.00), Larry Todd Edwards ($105,894.45), Masaru Matsuda ($289,430.15), Patrick Burnett ($455,446.61), Terrie Curran ($94,253.95), and Todd Franklin Watanabe ($227,550.00).

Insiders have sold a total of 231,532 Arcutis Biotherapeutics shares in the last 24 months for a total of $2,511,119.64 sold.

Arcutis Biotherapeutics Key Executives



This page (NASDAQ:ARQT) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners